920 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
21 Recruiting Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care
Condition: Non-Small Cell Lung Carcinoma (NSCLC)
Intervention: Other: Survey
22 Recruiting IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases
Condition: Non-Small Cell Lung Carcinoma
Interventions: Radiation: IMRT;   Radiation: WBRT;   Drug: erlotinib
23 Recruiting Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM
Conditions: Non Small Cell Lung Cancer (NSCLC);   Malignant Pleural Mesothelioma (MPM)
Intervention: Drug: Vinorelbine
24 Recruiting Genomic Landscape of Ceritinib
Conditions: Carcinoma, Non-Small-Cell Lung;   Non-small Lung Cancer;   Non-Small Cell Lung Cancer
25 Not yet recruiting Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Drug: pembrolizumab, paclitaxel
26 Not yet recruiting Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer
Condition: Resectable Non-small Lung Cancer
Interventions: Procedure: blood drawn;   Procedure: surgical resection of cancer
27 Available Rociletinib (CO-1686) USA Expanded Access Program
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Rociletinib
28 Recruiting Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: CC-486;   Drug: Pembrolizumab;   Drug: Placebo
29 Not yet recruiting Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: MGCD265
30 Not yet recruiting A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
Conditions: Carcinoma, Renal Cell;   Kidney Diseases;   Kidney Neoplasms;   Urogenital Neoplasms;   Urologic Diseases;   Urologic Neoplasms;   Neoplasms by Histologic Type;   Neoplasms;   Clear-cell Metastatic Renal Cell Carcinoma;   Melanoma;   Triple Negative Breast Cancer;   Bladder Cancer;   Head and Neck Cancer;   Non-small Cell Lung Cancer
Intervention: Drug: Combination of Varlilumab and Atezolizumab
31 Not yet recruiting Abscopal Effect for Metastatic Non-small Cell Lung Cancer.
Conditions: Non-small Cell Lung Cancer;   Metastatic Non-small Cell Lung Cancer;   Radiotherapy;   Thymalfasin
Interventions: Radiation: Radiotherapy;   Drug: Thymalfasin
32 Not yet recruiting Study of 1st Line Therapy Study of MEDI4736 With Tremelimumab Versus SoC in Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE).
Condition: Non Small Cell Lung Carcinoma (NSCLC)
Interventions: Biological: MEDI4736+Tremelimumab;   Drug: Paclitaxel + carboplatin;   Drug: Gemcitabine + cisplatin;   Drug: Gemcitabine + carboplatin;   Drug: Pemetrexed + cisplatin;   Drug: Pemetrexed + carboplatin
33 Not yet recruiting Abscopal Effect for Metastatic Small Cell Lung Cancer
Conditions: Small Cell Lung Cancer;   Radiotherapy;   Thymalfasin
Interventions: Radiation: Radiotherapy;   Drug: Thymalfasin
34 Recruiting Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Apatinib single agent arm
35 Not yet recruiting A Randomized, Multicenter, Double-Blind, Phase 3 Study of Nivolumab, Nivolumab in Combination With Ipilimumab, or Placebo as Maintenance Therapy in Subjects With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based First Line Chemotherapy
Condition: Lung Cancer
Interventions: Biological: Nivolumab;   Biological: Ipilimumab;   Other: Placebo
36 Recruiting Phase 1 Combination Study of MM-151 and MM-121
Conditions: Colorectal Cancer;   Non-small Cell Lung Cancer;   Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: MM-151;   Drug: MM-121
37 Not yet recruiting Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors
Conditions: Prostate Cancer;   Non-Small Cell Lung Cancer;   Breast Cancer
Interventions: Drug: RQ-00000007;   Drug: Gemcitabine
38 Not yet recruiting Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors
Conditions: Solid Tumors;   Carcinoma, Non-Small Cell Lung;   Non-Small Cell Lung Cancer;   Non-Small-Cell Lung Carcinoma;   Nonsmall Cell Lung Cancer
Interventions: Drug: Cisplatin;   Drug: Gemcitabine;   Drug: Talazoparib
39 Recruiting Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Pyrotinib
40 Not yet recruiting Erlotinib Hydrochloride and Hsp90 Inhibitor AT13387 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer
Conditions: Recurrent Non-Small Cell Lung Carcinoma;   Stage IV Non-Small Cell Lung Cancer
Interventions: Drug: Erlotinib Hydrochloride;   Drug: Hsp90 Inhibitor AT13387;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years